Fibrinolytics and Antifibrinolytics [electronic resource] /
Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.
Main Authors: | , |
---|---|
Format: | Texto biblioteca |
Language: | eng |
Published: |
Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,
2001
|
Subjects: | Medicine., Pharmacology., Cardiology., Biochemistry., Biomedicine., Pharmacology/Toxicology., Biochemistry, general., |
Online Access: | http://dx.doi.org/10.1007/978-3-642-56637-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
KOHA-OAI-TEST:213482 |
---|---|
record_format |
koha |
spelling |
KOHA-OAI-TEST:2134822018-07-30T23:47:04ZFibrinolytics and Antifibrinolytics [electronic resource] / Bachmann, F. editor. SpringerLink (Online service) textBerlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,2001.engSection I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.Medicine.Pharmacology.Cardiology.Biochemistry.Biomedicine.Pharmacology/Toxicology.Biochemistry, general.Cardiology.Springer eBookshttp://dx.doi.org/10.1007/978-3-642-56637-0URN:ISBN:9783642566370 |
institution |
COLPOS |
collection |
Koha |
country |
México |
countrycode |
MX |
component |
Bibliográfico |
access |
En linea En linea |
databasecode |
cat-colpos |
tag |
biblioteca |
region |
America del Norte |
libraryname |
Departamento de documentación y biblioteca de COLPOS |
language |
eng |
topic |
Medicine. Pharmacology. Cardiology. Biochemistry. Biomedicine. Pharmacology/Toxicology. Biochemistry, general. Cardiology. Medicine. Pharmacology. Cardiology. Biochemistry. Biomedicine. Pharmacology/Toxicology. Biochemistry, general. Cardiology. |
spellingShingle |
Medicine. Pharmacology. Cardiology. Biochemistry. Biomedicine. Pharmacology/Toxicology. Biochemistry, general. Cardiology. Medicine. Pharmacology. Cardiology. Biochemistry. Biomedicine. Pharmacology/Toxicology. Biochemistry, general. Cardiology. Bachmann, F. editor. SpringerLink (Online service) Fibrinolytics and Antifibrinolytics [electronic resource] / |
description |
Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System -- 1 The Fibrinolytic System and Thrombolytic Agents -- 2 Plasminogen and Streptokinase -- 3 Tissue-type Plasminogen Activator (tPA) -- 4 Urinary-type Plasminogen Activator (uPA) -- 5 The Inhibitors of the Fibrinolytic System -- 6 Assembly of the Plasminogen System on Cell Surfaces -- Section II: Clinical Use of Thrombolytic Agents -- In Acute Myocardial Infarction -- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex -- 8 Tissue-Type Plasminogen Activator (tPA) -- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase) -- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial -- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI -- Thrombolytic Treatment of other Clinical Thromboembolic Conditions -- 12 New Concepts in Thrombolysis of Pulmonary Embolism -- 13 Deep Venous Thrombosis -- 14 Peripheral Arterial Occlusions -- 15 Thrombotic Cerebrovascular Disease -- Thrombolytic Agents in Development, Biochemistry, Pharmacology — Efficacy in Animal Experiments and First Clinical Trials -- 16 Staphylokinase -- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator -- 18 Thrombus-Targeting of Plasminogen Activators -- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase -- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator -- Autifibrinolytic Agents -- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents. |
format |
Texto |
topic_facet |
Medicine. Pharmacology. Cardiology. Biochemistry. Biomedicine. Pharmacology/Toxicology. Biochemistry, general. Cardiology. |
author |
Bachmann, F. editor. SpringerLink (Online service) |
author_facet |
Bachmann, F. editor. SpringerLink (Online service) |
author_sort |
Bachmann, F. editor. |
title |
Fibrinolytics and Antifibrinolytics [electronic resource] / |
title_short |
Fibrinolytics and Antifibrinolytics [electronic resource] / |
title_full |
Fibrinolytics and Antifibrinolytics [electronic resource] / |
title_fullStr |
Fibrinolytics and Antifibrinolytics [electronic resource] / |
title_full_unstemmed |
Fibrinolytics and Antifibrinolytics [electronic resource] / |
title_sort |
fibrinolytics and antifibrinolytics [electronic resource] / |
publisher |
Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, |
publishDate |
2001 |
url |
http://dx.doi.org/10.1007/978-3-642-56637-0 |
work_keys_str_mv |
AT bachmannfeditor fibrinolyticsandantifibrinolyticselectronicresource AT springerlinkonlineservice fibrinolyticsandantifibrinolyticselectronicresource |
_version_ |
1756269211365146624 |